Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Matthews

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapyI N Olver, C R Laidlaw, J P Matthews, et al.
Leukemia & Lymphoma|July 31, 1998
Prognostic markers of disease activity in Hodgkin's diseaseA J Martinow, K Yuen, I A Cooper, et al.
The Medical Journal of Australia|September 9, 2000
A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysisD Rischin, M A White, J P Matthews, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
Immune parameters of mice bearing human head and neck cancerA Taitz, G Petruzzelli, A S Pak, et al.
The American Journal of Cardiology|November 15, 1991
Prognostic features of children with idiopathic dilated cardiomyopathyH B Wiles, P D McArthur, A B Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazineJ F Bishop, I N Olver, M M Wolf, et al.
Cancer Treatment Reports|November 1, 1987
Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapyJ F Bishop, M Wolf, J P Matthews, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancerR J Hicks, V Kalff, M P MacManus, et al.
International Journal of Radiation Oncology, Biology, Physics|May 31, 2001
High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapyM P MacManus, R J Hicks, J P Matthews, et al.
American Journal of Clinical Pathology|November 1, 1985
Acute changes in iron metabolism following myocardial infarctionJ D Griffiths, L J Campbell, I W Woodruff, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapyI N Olver, C R Laidlaw, J P Matthews, et al.
Leukemia & Lymphoma|July 31, 1998
Prognostic markers of disease activity in Hodgkin's diseaseA J Martinow, K Yuen, I A Cooper, et al.
The Medical Journal of Australia|September 9, 2000
A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysisD Rischin, M A White, J P Matthews, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
Immune parameters of mice bearing human head and neck cancerA Taitz, G Petruzzelli, A S Pak, et al.
The American Journal of Cardiology|November 15, 1991
Prognostic features of children with idiopathic dilated cardiomyopathyH B Wiles, P D McArthur, A B Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazineJ F Bishop, I N Olver, M M Wolf, et al.
Cancer Treatment Reports|November 1, 1987
Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapyJ F Bishop, M Wolf, J P Matthews, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancerR J Hicks, V Kalff, M P MacManus, et al.
International Journal of Radiation Oncology, Biology, Physics|May 31, 2001
High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapyM P MacManus, R J Hicks, J P Matthews, et al.
American Journal of Clinical Pathology|November 1, 1985
Acute changes in iron metabolism following myocardial infarctionJ D Griffiths, L J Campbell, I W Woodruff, et al.
Pageof 8